Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Prescribers should document their clinical rationale, including the absence of contraindications, in the patient's medical record
Independent pharmacies file an antitrust suit against a PBM
It is currently MHRA and NICE approved for treating bladder pain (interstitial cystitis of the bladder) , so it can be repurposed as an osteoarthritis treatment
The peptide received FDA Orphan Drug designation and Fast Track designation for neuropathic pain in sarcoidosis, plus EU orphan designation development incentives reflecting the regulatory agencies recognition of the unmet medical need and the scientific promise of the innate repair receptor mechanism
US$ 25.33
US$ 24.06
US$ 24.10
US$ 22.17
US$ 29.85
US$ 29.92
US$ 26.38
